Log in to save to my catalogue

Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflamm...

Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflamm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2433032945

Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model

About this item

Full title

Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model

Publisher

New York: Springer US

Journal title

Neurochemical research, 2020-09, Vol.45 (9), p.2128-2142

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

The abnormal production of short chain fatty acid (SCFAs) caused by gut microbial dysbiosis plays an important role in the pathogenesis and progression of Parkinson’s disease (PD). This study sought to evaluate how butyrate, one of SCFAs, affect the pathology in a subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) treated mo...

Alternative Titles

Full title

Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2433032945

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2433032945

Other Identifiers

ISSN

0364-3190,1573-6903

E-ISSN

1573-6903

DOI

10.1007/s11064-020-03074-3

How to access this item